Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China
Pamukkale University, Denizli, Turkey
The Second Affiliated Hospital of Zhejiang University anesthesiology department, Hangzhou, Zhejiang, China
Inselspital Bern, Bern, Switzerland
Selcuk University Faculty of Dentistry, Konya, Selcuklu, Turkey
Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
NYCHHC - Jacobi Medical Center and North Central Bronx Hospital, Bronx, New York, United States
Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.